The Best And Worst Performing Biotech Stocks In July
19:19 EDT 31 Jul 2012 | Forbes
Alnylam, the pioneer in using RNAi technology that silences genes before they can become proteins, topped biotechnology stocks in July after its shares soared following a July 16 release of data on an experimental drug to treat a rare genetic disease..
Original Article: The Best And Worst Performing Biotech Stocks In July
More From BioPortfolio on "The Best And Worst Performing Biotech Stocks In July"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
